ABSTRACT
INTRODUCTION
The members of the thyroid hormone receptor (TR) and of the retinoic acid receptor (RAR) family act on vertebrate development and homeostasis by binding to specific DNA sequences (1) (2) (3) , thereby regulating transcription of target genes (4, 5) . TR and RAR are ligand inducible transcription factors which repress transcription in the absence of hormone and induce expression in the presence of specific ligand (6) . Depending on the promoter context or type of response element ligand dependent repression has been described as well (7) (8) (9) (10) . Here we are analyzing the repression in the absence of ligand which is mediated by an active silencing mechanism even acting on a minimal promoter composed of only a TATA box (1 1) . Variant forms of these factors which are unable to bind hormone represent constitutive repressors (6, 12) . Recently the analysis of thyroid hormone resistance syndrome patients illustrated the importance of this repression function. A dominant negative TR mutant is causing a severe impairment of physical and mental development, which is not seen upon TR gene deletion (13) . Similarly, a major role for silencing is demonstrated by the chicken oncogene product v-erbA. It does not bind T3 due to mutations in its ligand binding domain (14) , it functions as a constitutive silencer protein (6, 11, 12, 15) and it interferes with normal erythropoiesis (16) (17) (18) (19) (20) . A natural mutant of v-erbA (Pro 399 to Arg) lacks the oncogenic and the silencing activity (21, 22) .
Deletion analysis of v-erbA assigned the silencing function to about 300 C-terminal amino acids (a.a.) of the protein (23) . Corresponding domains of TR and RAR were able to mediate both, repression and ligand dependent induction. In contrast to other repression mechanisms (7) (8) (9) (24) (25) (26) (27) , nothing is known about the structural requirement for silencing domains, a prerequisite for the mechanistic understanding of this effect (24) .
The finding that both TR and RAR as well as other members of the gene family form heterodimers with RXRs adds even more complexity to the transcription regulation by these factors (28 -34) . The natural ligand for RXR was shown to be 9-cis retinoic acid (9-cis-RA), a stereoisomer of all-trans-retinoic acid, the ligand for RAR (35, 36) . Heterodimerization of TR with RXR strongly enhances both, specific DNA binding measured in vitro (28, 30, 37, 38) and transcriptional induction in transient transfection experiments (31, 32, 34, 39) or in vitro (40) . It was not known whether RXR exhibits or contributes to the repression function in the ligand free heterodimer with TR or RAR.
Here we show that the v-erbA silencing domain is composed of at least two regions, both of which are non functional on their own. Repression activity is restored when both regions are present in one protein, but interestingly also when present on two different proteins which are able to form heterodimers.
We find that a region of the RXR domain, corresponding to the minimal silencing domain of v-erbA, does not mediate transcriptional repression, although it readily displays hormonal induction. In addition it does not contribute to TR or v-erbA silencing when present in a heterodimer.
RESULTS
V-erbA contains a large silencing domain Based on previous results (23) we wanted to define more precisely regions of v-erbA required for transcriptional repression. Therefore we fused the C-terminal part of v-erbA to the *To whom correspondence should be addressed gel retardation experiments and found to be similar for all the mutants (23 and data not shown).
Transfection of an expression vector coding for the GAL4-DBD had no effect on UAS driven CAT expression in Ltk-cells (Fig. 1) To further prove the formation of heterodimers via the GAL4-DBD, an independent in vitro assay was performed. Fusion proteins with the Glutathione-S-transferase were bacterially expressed, bound to Glutathione-Sepharose and used to precipitate specifically interacting in vitro translated, 35S-labelled proteins (input Fig. 3b, lanes 4, 8, 10, 13 ). In each experiment in vitro translated, 35S-labelled luciferase (L) (input Fig. 3b , lanes 7 and 9) was added as a specificity control. When GST-GAL-erb 508 -639 was coupled to the beads, interaction could be detected with labelled GAL-erb 508 -639 (lane 14), GAL-erb 362-468/508-639 (lane 11), GAL-erb 409-639 (lane 6) and GAL-erb 362-508 (lane 3). When only GST was used no radioactive band was visible (lanes 2, 5, 12, 15). In addition, luciferase was not retained in any of these experiments, indicating that the protein-protein interactions are specific. The interaction was mediated by the dimerisation function of the GAL4-DBD, as the fusion proteins GST-erb 508 -639 or GSTerb 362-508 did not interact with GAL-erb 508-639 (lane 16) or GAL-erb 362 -508 (lane 1), respectively.
In order to measure the effect of heterodimers on UAS-driven transcription, we compared the reporter gene activity after coexpression of two fusion proteins to the reference transcription obtained with a single protein. To avoid differences in the transfection and expression conditions, we added equal amounts of GAL4-DBD expression plasmid in the reference transfection as well. This allows a direct comparison of the effects due to GAL4-DBD/GAL-fusion protein heterodimers (in the reference transfection) to those mediated by GAL-fusion A/GAL-fusion B heterodimers (in the co-expression experiment).
Reference expression of GAL-erb 362-508 or GALerb 409-639 is deficient in silencing. Co-expression of both fusion proteins leads to a 2.6-fold repression of CAT transcription (Fig. 4, line 1) . Heterodimers between GAL-erb 362-508 and GAL-erb 508-639 showed a clear 6-fold synergistic repression as opposed to the reference transfections (line 2). Further Nterminal deletion of the silencing domain in Gal-erb 557 -639 and Gal-erb 617 -639 resulted in loss of the complementation In order to ensure that the complementation effect is not due to a higher amount of GAL-verbA fusion proteins in comparison to the reference transfection, we tested combinations of heterodimeric partners containing identical putative silencing regions. Neither of these combinations led to significant repression (Fig. 4, lines 5+6 ). In addition, increasing the amount of transfected GAL-erb 362-508 in the absence of a second expression vector did not result in silencing (data not shown).
Furthermore, we were interested to know whether a deletion mutant mediating residual silencing activity could synergize with other subdomains. Therefore we tested GAL-erb 362-468/ 508-639. The repression function of this fusion protein is dramatically increased when co-expressed with different heterodimeric partners (Fig. 5) . Both, the N-terminal v-erbA subregion (GAL-erb 362-508) or the C-terminal region (GALerb 409-639) fused to the GAL4-DBD synergize efficiently in silencing activity with GAL-erb 362-468/508-639 (Fig. 5) . One of these combinations (Fig. 5, line 1 ) yields near to wild type activity. Another internal deletion mutant with a severe defect in silencing, GAL-erb 362-434/468-639, was unable to complement GAL-erb 362-508 (Fig. 5, line 3) .
We conclude that the silencing domain of v-erbA is composed very low, negative effect in thi induction we used all-trans RA converted to 9-cis-RA by stereo These results suggest that, althi is functional in hormone depend to mediate a significant repress GAL-RXR does not contribul a heterodimer with GAL-TR RXR was shown to form hetero members of the thyroid hormon we have shown above, it does ni on its own, we wanted to knov to help its heterodimeric partner to exclude effects due to differ differential dimerization eff heterodimeric complexes, we proteins for this experiment. dimerization is directed by the all the homo-and heterodimers. I or of GAL-TR along with GALA independent of the addition of GAL4-DBD with the fusion GA silencing mediated by GAL-ver of RA (Fig. 7) . Similarly, co-e. to 100-fold relative to GAL-TR did not influence repression in t shown). These results were not since extended assays with lar strongly increased basal level acti RXR effect on repression. In the induction expected from GAL-R, case. The weaker silencing activ relieved. (Fig. 7) . Replacement of biological oncogenic and silencing function (21, 22) . In this context the internal deletion mutant GAL-erb 346-389/ *L-RXR shows no effect on the 434-639, which has Pro 399 deleted, is important. It is strongly xbA or GAL-TR in the absence impaired in silencing function, but, in contrast to deletion mutant xpor GAL-verbA) of GAL-RXR GAL-erb 409-639, it still retains some negative activity. UAS-tkCAT 4, lane 5). The dimerization interface is contributed by the common GAL4-DBD, as its deletion abolished the interaction (Fig. 3b, lanes 1 and 16) . Gel retardation experiments using with v-erbA or TR in silencing. The results obtained using the internal deletion mutants and the heterodimeric complexes point to region 434-468 as being absolutely required for function. It has to be present in at least one of the heterodimeric partners. Deletion of only these amino acids in GAL-erb 346-434/468-639 leads to a non-functional protein (Fig. 2, line 3) , which cannot be complemented by a fusion protein (GAL-erb 362-508, Fig. 5, line 3) shown to synergize in other cases (Fig. 4, lines 1 and 2) .
Recently, synergism in silencing between two non-functional subdomains of the hTR(3 C-terminal region was described using GAL4 fusion proteins and a reporter gene containing four UAS binding sites (42) . In our system, using a single UAS, coexpression of the corresponding v-erbA fusion proteins GALerb 362-439 and GAL-erb 409-639 led to a weak, but reproducible synergism as well.
Synergism between transcriptional activating domains is a general phenomenon. Steroid receptors contain two or more transactivation domains cooperating for full activity (43 -45) . In case of the human estrogen receptor two activation functions AF 1 and AF2 were shown to synergize when present on different DNA binding entities (45) . Recently the transcription factor TEF1 was shown to require at least two out of three subdomains for activation function, each of which is inactive when tested individually in a GALA fusion protein (46) . Synergism within a heterodimer was described for the hormone dependent activation by RXR/RAR complexes (29, 30, 31, 33, 39) . It was shown that heterodimers formed of one partner containing the N-terminal AF1 domain and the other partner containing the C-terminal AF2 domain displayed synergistic activation function (47) . This synergism was also seen if one of the partners lacks a corresponding binding site in the regulated promoter. Specific synergistic silencing was described for v-erbA or TR with the protein Nepl binding close to a thyroid hormone responsive element in the chicken lysozyme silencer -2.4 kb (11, 48) . Here we describe a synergism between two silencer subdomains.
The mechanism for this synergism is still unclear. Direct interaction of hTRa 1 (49) and the C-terminus of hTR(3 (42) with TFIIB has been demonstrated. This interaction is relieved in the presence of T3 (42) Cell culture and transfections Ltk-cells, CVI and COSI cells were grown in DME-medium (Gibco) supplemented with 10% fetal calf serum, 100 U/ml penicillin and 100 pjg/ml streptomycin.
DNA transfer into CVI cells was performed using the calcium phosphate precipitation method. Ltk-cells were transfected as described (52) . 2 x 106 cells were suspended in DNA -DEAEdextran solution (1 pmol reporter and 0.5 pmol expression plasmids) and incubated for 30 min. After adding directly 7 ml medium, cells were seeded on a 6 cm dish and grown for [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] that GAIA fusion proteins show higher silencing effects on a UAS h before harvesting. Transfections were done in triplicate and performed in at least two independent experiments. Transfections into COSI cells were done by a similar DEAE -dextran suspension method using 6 pmole of DNA on 107 cells. After 1 h incubation in the DNA solution, a DMSO shock was performed for 3 min, the cells were taken up in 30 ml PBS and 10 ml medium, spun down, seeded on a 15 cm dish and grown for 48 h before harvesting.
For hormonal induction experiments, the serum was depleted of thyroid hormone and retinoic acid by extensive charcoal stripping. The cells were kept for at least 24 h in depleted medium before transfection, after transfection l0-7 M 3,5,3'-trijodthyronine or 10-6 M retinoic acid was added. CAT-assays were performed as described (53 Protein-protein interactions in vitro Protein-protein interactions were assayed mainly as described (42) .
GST-fusion-proteins were expressed in E. coli BL21 cells (55) . Cells were harvested by centrifugation and resuspended in NENT buffer (100 mM NaCl, 1 mM EDTA, 20 mM Tris pH 8.0 and 0.5% NP-40). Cells were lysed by three freeze-thaw cycles and the cellular debris was removed by centrifugation. Glutathione-Sepharose 4B beads were washed with NENT and 10 ,ul of beads were incubated with 100 ,ul of lysate containing the GST-fusion protein for 30 min at room temperature. Subsequently, the supernatant was removed and the beads were incubated with 10% milk powder in NENT for 15 min at room temperature. The beads were washed twice with 1 ml NENT and once with 1 ml transcription washing buffer (20 mM Hepes pH 7.9, 60 mM NaCl, 1 mM DTT, 6 mM MgCl2, 8% glycerine and 0.1 mM EDTA). In vitro translated and radiolabeled protein were obtained using a TNT-kit (Promega). 5 yd of crude lysate were incubated with the beads in 100 Al transcription washing buffer for 1 h at room temperature. Finally the beads were washed (5 x 1 ml of NENT) and proteins were solubilized in SDS-loading buffer and analyzed on SDS -PAGE. Gels were amplified with fluorigraphic reagent (Amersham) and bands were visualised by autoradiography.
